<div class="container">

<table style="width: 100%;"><tr>
<td>DSU3L</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>DSU mapping from EQ-5D-3L to EQ-5D-5L</h2>

<h3>Description</h3>

<p>Data for age and sex based mapping from EQ-5D-3L dimensions or utility index
score to EQ-5D-5L for China, Germany, Japan, Netherlands, South Korea, Spain
and UK.
</p>


<h3>Usage</h3>

<pre><code class="language-R">DSU3L
</code></pre>


<h3>Format</h3>

<p>An object of class <code>data.frame</code> with 2430 rows and 22 columns.
</p>


<h3>Source</h3>

<p>Hernández Alava M, Pudney S, Wailoo A. Estimating the Relationship Between EQ-5D-5L and EQ-5D-3L: Results from a UK Population Study. Pharmacoeconomics. 2023 Feb;41(2):199-207. doi: 10.1007/s40273-022-01218-7. Epub 2022 Nov 30. <a href="https://pubmed.ncbi.nlm.nih.gov/36449173/">PubMed</a>
</p>
<p>Hernández-Alava M, Pudney S. Econometric modelling of multiple self-reports of health states: The switch from EQ-5D-3L to EQ-5D-5L in evaluating drug therapies for rheumatoid arthritis. J Health Econ. 2017 Sep;55:139-152. doi: 10.1016/j.jhealeco.2017.06.013. Epub 2017 Jul 4. <a href="https://pubmed.ncbi.nlm.nih.gov/28778350/">PubMed</a>.
</p>
<p><a href="https://www.sheffield.ac.uk/nice-dsu/methods-development/mapping-eq-5d-5l-3l">NICE DSU mapping website</a>.
</p>


</div>